Bora Pharmaceuticals Hosted Iowa Governor Kim Reynolds at Subsidiary Upsher-Smith to Discuss U.S. Supply Chain and Regional Collaboration, and Presented at Regional Collaboration

MINNESOTA, UNITED STATES & TAIPEI, TAIWAN – Media OutReach Newswire – 23 July 2025 – Bora Pharmaceuticals (TWSE: 6472, Bora) welcomed Iowa Governor Kim Reynolds to their Maple Grove, Minnesota facility for a roundtable discussion and site tour focused on advancing pharmaceutical innovation and exploring opportunities for regional collaboration. The Company also hosted the Governor at its subsidiary Upsher-Smith Laboratories, LLC (Upsher-Smith), a Midwest-based pharmaceutical company focused on specialty brands. At the same time, CDMO Division President of Bora presented at Regional Collaboration- U.S.A Session” of Bio Asia on Taiwan Pharma’s path to U.S. Market Success.

As part of the Governor’s domestic mission trip, Governor Reynolds met with leaders from Bora Group to discuss onshoring pharmaceutical manufacturing, strengthening supply chain integration across the Midwest, and expanding contract development and manufacturing.

“This is a great example of how Iowa can lead the nation in revitalizing domestic manufacturing and strengthening critical industries,” said Governor Kim Reynolds. “Bora Group and Upsher-Smith are investing in people, innovation, and infrastructure; the very pillars of the high-value growth we’re driving in Iowa. By fostering regional partnerships and expanding U.S. supply chains, we’re not only advancing healthcare – we’re creating jobs, fueling economic growth, and enhancing long-term competitiveness for our states.”

The visit began with a tour of the Maple Grove manufacturing facility and a forward-looking discussion about growing domestic manufacturing and CDMO (Contract Development and Manufacturing) opportunities – both critical components of a resilient pharmaceutical supply chain. Bora group CDMO leaders shared insights into the company’s integrated global network, pharmaceutical development and manufacturing capabilities, and vision for expanding CDMO partnerships in the U.S..

“Bora Pharmaceuticals is deeply committed to strengthening pharmaceutical manufacturing here in the U.S.” said Dennis Hall, Vice President of Bora Pharmaceuticals. “As a global CDMO with a growing domestic footprint, we see tremendous opportunity for investment, innovation, and collaboration. We appreciate leaders like Governor Reynolds who understand the critical role of a resilient, U.S.-based supply chain in ensuring patients have consistent access to essential medicines.”

Additionally, during the roundtable, executives from Upsher-Smith highlighted the Company’s branded portfolio and its impact on patient care through high-quality medications, including treatments for pediatric rare diseases.

Discussions also focused on Bora’s robust production capabilities in the U.S. and ongoing commitment to onshoring operations. Such was reiterated at the premise of Bio Asia, where J.D. Mowery, CDMO Division President of Bora Pharmaceuticals, presented “Taiwan Pharma’s Path to U.S. Market Success”. To date, the company has invested hundreds of millions of dollars in U.S. domestic infrastructure with continuous CAPEX plans.Hashtag: #BoraPharmaceuticals

The issuer is solely responsible for the content of this announcement.

About Bora

Founded in 2007, Bora Pharmaceuticals (“Bora” or “the Company”, 6472.TW) is a leading pharmaceutical services company with a vision and goal of “Contributing to Better Health All Over the World”. Operating under a “Dual Engine” model that integrates CDMO and commercial expertise, we empower pharmaceutical and biotech partners to optimize product development, accelerate launches, and scale supply to meet global patient needs. At the same time, we actively broaden R&D and sales infrastructure, focusing on niche and rare disease markets to improve patients’ quality of life.

By investing in talent, infrastructure, and biologics expansion, Bora continues to transform operations and achieve sustainable growth. For more information, visit www.bora-corp.com.

About the Iowa Economic Development Authority

The Iowa Economic Development Authority (IEDA) strengthens the state’s economic foundation by fostering business growth, community development, and vibrant places to live and work. IEDA administers programs designed to attract and retain businesses, encourage innovation, support entrepreneurs, and promote Iowa as a premier destination for investment, travel and talent. With a focus on collaboration and long-term impact, IEDA works with public and private partners to advance economic opportunities and improve quality of life for all Iowans. Learn more at www.iowaeda.com.